Tokyo Tape
Sign in
← Yamashita Health Care Holdings

Quarterly report · Q3

9265.TEDINET S100T8KZ
Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥45.4bn2023-06-01 → 2024-02-29Cons.Net sales
Revenue¥58.2bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥41.7bn2022-06-01 → 2023-02-28Cons.Net sales
Operating income¥830m2023-06-01 → 2024-02-29Cons.Operating income
Operating income¥895m2022-06-01 → 2023-02-28Cons.Operating income
Ordinary income¥871m2023-06-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.2bn2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥936m2022-06-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥721m2023-06-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥333m2022-06-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥442m2023-06-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥219m2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥438m2023-06-01 → 2024-02-29Cons.Profit loss
Net income−¥3m2022-06-01 → 2023-02-28Cons.Profit loss
Total assets¥25.6bnat 2024-02-29Cons.Assets
Total assets¥24.6bnat 2023-05-31Cons.Assets
Total assets¥22.5bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥17.2bnat 2024-02-29Cons.Liabilities
Total liabilities¥16.6bnat 2023-05-31Cons.Liabilities
Net assets / equity¥8.4bnat 2024-02-29Cons.Net assets
Net assets / equity¥7.9bnat 2023-05-31Cons.Net assets
Net assets / equity¥7.7bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥4.5bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥5.8bnat 2023-05-31Cons.Cash and deposits
EPS (basic)¥173.232023-06-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-14.832023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥85.832022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.462022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥79.442022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
Equity ratio32.8%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio32.2%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.2%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-06-01 → 2024-02-29¥0
Reconciling Itemsreconcilingrevenue intersegment2023-06-01 → 2024-02-29¥0
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2024-02-29−¥844m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2023-06-01 → 2024-02-29¥209m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2023-06-01 → 2024-02-29¥209m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥0
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2023-06-01 → 2024-02-29¥2m
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue2023-06-01 → 2024-02-29¥45.1bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue external2023-06-01 → 2024-02-29¥45.1bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥0
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentsegment profit2023-06-01 → 2024-02-29¥1.7bn
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue2023-06-01 → 2024-02-29¥51m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue external2023-06-01 → 2024-02-29¥51m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentsegment profit2023-06-01 → 2024-02-29¥1m
—segment totalrevenue2023-06-01 → 2024-02-29¥45.4bn
—segment totalrevenue external2023-06-01 → 2024-02-29¥45.4bn
—segment totalrevenue intersegment2023-06-01 → 2024-02-29¥0
—segment totalsegment profit2023-06-01 → 2024-02-29¥1.7bn
Reconciling Itemsreconcilingrevenue2022-06-01 → 2023-02-28−¥11m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2023-02-28−¥11m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥690m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2022-06-01 → 2023-02-28¥211m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2022-06-01 → 2023-02-28¥211m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥0
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2022-06-01 → 2023-02-28¥10m
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue2022-06-01 → 2023-02-28¥41.5bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue external2022-06-01 → 2023-02-28¥41.5bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥11m
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentsegment profit2022-06-01 → 2023-02-28¥1.6bn
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue2022-06-01 → 2023-02-28¥50m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue external2022-06-01 → 2023-02-28¥50m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentsegment profit2022-06-01 → 2023-02-28¥0
—segment totalrevenue2022-06-01 → 2023-02-28¥41.7bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥41.7bn
—segment totalrevenue intersegment2022-06-01 → 2023-02-28¥11m
—segment totalsegment profit2022-06-01 → 2023-02-28¥1.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 366
ItemContextValueUnit
Investments and other assetsPrior1YearInstant1614000000JPY
Investments and other assetsCurrentQuarterInstant1872000000JPY
Noncurrent assetsPrior1YearInstant5052000000JPY
Noncurrent assetsCurrentQuarterInstant5345000000JPY
AssetsPrior1YearInstant24568000000JPY
AssetsCurrentQuarterInstant25633000000JPY
Notes and accounts payable tradePrior1YearInstant7793000000JPY
Notes and accounts payable tradeCurrentQuarterInstant8685000000JPY
Electronically recorded obligations operating clPrior1YearInstant6686000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant6962000000JPY
Income taxes payablePrior1YearInstant334000000JPY
Income taxes payableCurrentQuarterInstant29000000JPY
Provision for bonusesPrior1YearInstant693000000JPY
Provision for bonusesCurrentQuarterInstant211000000JPY
Short term loans payablePrior1YearInstant－JPY
Short term loans payableCurrentQuarterInstant30000000JPY
Other clPrior1YearInstant632000000JPY
Other clCurrentQuarterInstant565000000JPY
Current liabilitiesPrior1YearInstant16139000000JPY
Current liabilitiesCurrentQuarterInstant16484000000JPY
Net defined benefit liabilityPrior1YearInstant234000000JPY
Net defined benefit liabilityCurrentQuarterInstant240000000JPY
Other nclPrior1YearInstant270000000JPY
Other nclCurrentQuarterInstant499000000JPY
Noncurrent liabilitiesPrior1YearInstant504000000JPY
Noncurrent liabilitiesCurrentQuarterInstant739000000JPY
LiabilitiesPrior1YearInstant16644000000JPY
LiabilitiesCurrentQuarterInstant17224000000JPY
Capital stockPrior1YearInstant494000000JPY
Capital stockCurrentQuarterInstant494000000JPY
Capital surplusPrior1YearInstant627000000JPY
Capital surplusCurrentQuarterInstant627000000JPY
Retained earningsPrior1YearInstant6306000000JPY
Retained earningsCurrentQuarterInstant6625000000JPY
Treasury stockPrior1YearInstant-0JPY
Treasury stockCurrentQuarterInstant-0JPY
Shareholders equityPrior1YearInstant7427000000JPY
Shareholders equityCurrentQuarterInstant7747000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant563000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant720000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-84000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-72000000JPY
Valuation and translation adjustmentsPrior1YearInstant479000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant648000000JPY
Non controlling interestsPrior1YearInstant17000000JPY
Non controlling interestsCurrentQuarterInstant13000000JPY
Net assetsPrior1YearInstant7924000000JPY
Net assetsCurrentQuarterInstant8409000000JPY
Liabilities and net assetsPrior1YearInstant24568000000JPY
Liabilities and net assetsCurrentQuarterInstant25633000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-05-31pass
balance sheet identityconsolidated 2024-02-29pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass